Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Chinese Health Ivvestigation Of Nurse Aging

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT01994655
Recruitment Status : Unknown
Verified November 2013 by Bai Wen-Pei, Peking University First Hospital.
Recruitment status was:  Active, not recruiting
First Posted : November 26, 2013
Last Update Posted : November 26, 2013
Sponsor:
Information provided by (Responsible Party):
Bai Wen-Pei, Peking University First Hospital

Study Description
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information
Brief Summary:
Climacteric symptoms can be treated by doing exercise,not hormone replacement therapy.

Condition or disease Intervention/treatment Phase
Hot Flashes Other: Doing exercise Phase 1 Phase 2

Detailed Description:
Hormone replacement therapy(HRT) is the main therapy to climacteric symptoms. But HRT also has a lot of disadvantages, such as cardiovascular disease, breast cancer .In our previous investigation,we found that doing exercise is helpful for climacteric symptoms.So we want to make a detailed investigation to research it.
Study Design
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 2000 participants
Allocation: N/A
Intervention Model: Single Group Assignment
Masking: Single (Participant)
Primary Purpose: Health Services Research
Study Start Date : August 2008
Estimated Primary Completion Date : September 2015
Estimated Study Completion Date : September 2016

Resource links provided by the National Library of Medicine


Arms and Interventions
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Arm Intervention/treatment
Experimental: Doing exercise
We want to use Kupperman Index to assess the severity of climacteric symptoms,and assess the effect of doing exercise fof the climacteric symptoms
 Other: Doing exercise
We want to investigate the effects of exercise on climacteric symptoms
Other Name: Exercise

Other: Doing exercise
Doing exercise at least 6 months including walking, running, yoga etc.
Other Name: Exercise


Outcome Measures
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Primary Outcome Measures :
  1. KMI [ Time Frame: up to 2 years ]
    KMI is the short of Kupperman Index,which is a questionnaire to assesses the severity of climacteric symptoms.


Secondary Outcome Measures :
  1. blood lipid [ Time Frame: up to 2 years ]
    Blood lipid is an index to assess the effect of doing exercise.


Eligibility Criteria
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   40 Years to 55 Years   (Adult)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

- Women aged 40-55 who has climacteric symptoms

Exclusion Criteria:

- Women who have serious climacteric symptoms and other diseases which could interrupt the research.

Contacts and Locations
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

No Contacts or Locations Provided
More Information
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information
Layout table for additonal information
Responsible Party: Bai Wen-Pei, Peking University, Peking University First Hospital
ClinicalTrials.gov Identifier: NCT01994655    
Other Study ID Numbers: PEK-8357-wp
First Posted: November 26, 2013    Key Record Dates
Last Update Posted: November 26, 2013
Last Verified: November 2013
Keywords provided by Bai Wen-Pei, Peking University First Hospital:
climacteric symptoms
menopause
nurses
Additional relevant MeSH terms:
Layout table for MeSH terms
Hot Flashes
Signs and Symptoms